IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Imiquimod; Levocetirizine Dihydrochloride; Niacinamide.
| Product ID | 72934-1125_8738d91c-e670-0a37-e053-2991aa0a663e |
| NDC | 72934-1125 |
| Product Type | Human Prescription Drug |
| Proprietary Name | IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2% |
| Generic Name | Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Niacinamide 2% |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Sincerus Florida, LLC |
| Substance Name | IMIQUIMOD; LEVOCETIRIZINE DIHYDROCHLORIDE; NIACINAMIDE |
| Active Ingredient Strength | 5 g/100g; g/100g; g/100g |
| Pharm Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |